Opium: An emerging risk factor for gastric adenocarcinoma

International Journal of Cancer

Volumn 133, Issue 2, 2013, Pages 455-461

  Shakeri, Ramin ^a,b   Malekzadeh, Reza ^a   Etemadi, Arash ^a,b   Nasrollahzadeh, Dariush ^a,c   Aghcheli, Karim ^a,d   Sotoudeh, Masoud ^a   Islami, Farhad ^a,e   Pourshams, Akram ^a   Pawlita, Michael ^f   Boffetta, Paolo ^e   Dawsey, Sanford M ^b   Abnet, Christian C ^b   Kamangar, Farin ^a,b,g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g MORGAN STATE UNIVERSITY   (United States)

Author keywords

adenocarcinoma; cardia; opium

Indexed keywords

OPIATE;

ADULT; AGED; ARTICLE; CANCER RISK; CARDIA CARCINOMA; CASE CONTROL STUDY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; HUMAN CELL; IRAN; LIFESTYLE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STRUCTURED QUESTIONNAIRE; TOBACCO; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; BIOPSY; CARDIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; ODDS RATIO; OPIUM; QUESTIONNAIRES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84877824140     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28018     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Moy KA, Fan YH, Wang RW, et al. Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China. Cancer Epidemiol Biomarkers Prev 2010; 19: 2287-97.
3. Malekzadeh R, Derakhshan MH, Malekzadeh Z,. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med 2009; 12: 576-83.
4. Pakseresht M, Forman D, Malekzadeh R, et al. Dietary habits and gastric cancer risk in north-west Iran. Cancer Causes Control 2011; 22: 725-36.
5. Krejs GJ,. Gastric cancer: epidemiology and risk factors. Dig Dis 2010; 28: 600-3.
6. Yang ZR, Liu M, Peng XL, et al. Noscapine induces mitochondria-mediated apoptosis in human colon cancer cells in vivo and in vitro. Biochem Biophys Res Commun 2012; 421: 627-33.
7. Compare D, Rocco A, Nardone G,. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 2010; 14: 302-8.
8. Fuccio L, Eusebi LH, Bazzoli F,. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol 2010; 2: 342-7.
9. Ghadirian P, Stein GF, Gorodetzky C, et al. Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int J Cancer 1985; 35: 593-7.
10. Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008; 98: 1857-63.
11. Shakeri R, Kamangar F, Nasrollahzadeh D, et al. Is opium a real risk factor for esophageal cancer or just a methodological artifact? Hospital and neighborhood controls in case-control studies. PLoS One 2012; 7: e32711.
12. Mousavi MR, Damghani MA, Haghdoust AA, et al. Opium and risk of laryngeal cancer. Laryngoscope 2003; 113: 1939-43.
13. Hosseini SY, Safarinejad MR, Amini E, et al. Opium consumption and risk of bladder cancer: a case-control analysis. Urol Oncol 2010; 28: 610-16.
14. Behmard S, Sadeghi A, Mohareri MR, et al. Positive association of opium addiction and cancer of the bladder. Results of urine cytology in 3,500 opium addicts. Acta Cytol 1981; 25: 142-6.
15. Sadeghi A, Behmard S, Vesselinovitch SD,. Opium: a potential urinary bladder carcinogen in man. Cancer 1979; 43: 2315-21.
16. Masjedi MR, Naghan PA, Taslimi S, et al. Opium could be considered an independent risk factor for lung cancer: a case-control study. Respiration 2013; 85: 112-18
17. UNODC. World Drug Report-2011: United Nations Office on Drugs and Crime, 2011.
18. TobReg Wsgotpr. Waterpipe tobacco smoking: Health effects, research needs and recommended actions by regulators: World Health Organization (WHO), 2005.
19. Mohammadpour-Ahranjani B, Rashidi A, Karandish M, et al. Prevalence of overweight and obesity in adolescent Tehrani students, 2000-2001: an epidemic health problem. Public Health Nutr 2004; 7: 645-8.
20. Ladeiras-Lopes R, Pereira AK, Nogueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19: 689-701.
21. Tredaniel J, Boffetta P, Buiatti E, et al. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997; 72: 565-73.
22. Tramacere I, La Vecchia C, Negri E,. Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. Epidemiology 2011; 22: 344-9.
23. Akl EA, Gaddam S, Gunukula SK, et al. The effects of waterpipe tobacco smoking on health outcomes: a systematic review. Int J Epidemiol 2010; 39: 834-57.
24. Mahboubi E, Kmet J, Cook PJ, et al. Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer 1973; 28: 197-214.
25. Mousavi SM, Gouya MM, Ramazani R, et al. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20: 556-63.
26. Pourshams A, Khademi H, Malekshah AF, et al. Cohort profile: the Golestan cohort study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2010; 39: 52-59.
27. Malekshah AF, Kimiagar M, Saadatian-Elahi M, et al. Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr 2006; 60: 971-77.
28. Abnet CC, Saadatian-Elahi M, Pourshams A, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 2004; 13: 1068-70.
29. Gao L, Michel A, Weck MN, et al. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res 2009; 69: 6164-70.
30. Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009; 38: 978-88.
31. Nouraie M, Pietinen P, Kamangar F, et al. Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol Biomarkers Prev 2005; 14: 2087-92.
32. Webb PM, Law M, Varghese C, et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
33. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98: 1445-52.
34. Khademi H, Malekzadeh R, Pourshams A, et al. Increased mortality from opium use in the golestan cohort study: a prospective cohort study of 50,000 adults. BMJ 2012; 344: e2502.
35. Malaveille C, Friesen M, Camus AM, et al. Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk-factors in cancer of the bladder and esophagus. Carcinogenesis 1982; 3: 577-85.
36. Hewer T, Rose E, Ghadirian P, et al. Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet 1978; 2: 494-6.
37. Perry PE, Thomson EJ, Vijayalaxmi, et al. Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis 1983; 4: 227-30.
38. Friesen M, O'Neill IK, Malaveille C, et al. Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res 1985; 150: 177-91.
39. Khademi H, Kamangar F,. Esophageal cancer incidence trends in northeastern iran: comparing rates over 36 years. Arch Iran Med 2012; 15: 194-5.
40. Freedman ND, Abnet CC, Leitzmann MF, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165: 1424-33.
41. Tuyns AJ,. Oesophageal cancer in non-smoking drinkers and in non-drinking smokers. Int J Cancer 1983; 32: 443-4.
42. Brown LM, Hoover R, Silverman D, et al. Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol 2001; 153: 114-22.
43. Steevens J, Schouten LJ, Goldbohm RA, et al. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010; 59: 39-48.
44. Gajalakshmi CK, Shanta V,. Lifestyle and risk of stomach cancer: a hospital-based case-control study. Int J Epidemiol 1996; 25: 1146-53.
45. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008; 9: 667-75.